Changing the way cancer is treated
Kite Pharma (kitepharma.com) scores 83 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 85th percentile of 11052 Healthcare brands.
Kite Pharma is a biomedical engineering company focused on developing cell therapy treatments for cancer. Founded in 2009 and headquartered in Santa Monica, California, Kite is a subsidiary of Gilead Sciences. The company researches and manufactures cancer immunotherapy products, positioning itself as a leader in cell therapy innovation aimed at curing cancer for patients, healthcare providers, and researchers.
| Brand Name | Kite Pharma |
|---|---|
| Domain | kitepharma.com |
| Industry | Healthcare |
| Founded | 2009 |
| Headquarters | Santa Monica |
| Parent Company / Owner | Gilead Sciences |
| Main Competitors | Novartis (71/100), Bristol Myers Squibb (89/100), Legend Biotech, bluebird bio (57/100), Autolus Therapeutics, Allogene Therapeutics, Adaptimmune (80/100) |
Moz Domain Authority 51/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Kite Pharma has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Kite is dedicated to curing cancer. Learn about the science of cell therapy, our cancer research, and our cancer treatments in the pipeline." (Meta description: 23 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Kite Pharma?", Claude could identify the brand as of September 2026. Kite Pharma is a biotechnology company focused on developing cell therapies for cancer treatment, particularly CAR T-cell therapies. It became famous for developing Yescarta, one of the first CAR T-cell therapies approved for certain types of lymphoma, and was acquired by Gilead Best known for Developing Yescarta, one of the first FDA-approved CAR T-cell therapies for lymphoma, and being acquired by Gilead Sciences.
When asked "Best brands similar to Kite Pharma?", Claude would recommend Kite Pharma as of September 2026. Kite Pharma is a pioneer in CAR T-cell therapy and would be a natural mention alongside companies like Novartis or Bristol Myers Squibb when discussing leaders in cell therapy for cancer.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Kite Pharma's main competitors in Healthcare: Novartis (71/100), Bristol Myers Squibb (89/100), bluebird bio (57/100), Adaptimmune (80/100).
Sources: Brand Analyzer scan
Kite Pharma is a biomedical engineering company that develops cancer immunotherapy products, specifically cell therapy treatments. It was founded in 2009, is headquartered in Santa Monica, California, and operates as a subsidiary of Gilead Sciences.
Sources: Kite Pharma official site
Kite Pharma has moderate AI-search visibility, scoring 53/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 29, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Kite Pharma official site
Kite Pharma was founded in 2009. Kite Pharma operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Kite Pharma is headquartered in Santa Monica. Kite Pharma operates in the Healthcare category.
Sources: Wikidata
Kite Pharma researches, develops, and manufactures cell therapy treatments for cancer. The company focuses on innovative immunotherapy approaches designed to achieve cures, working across a diversified pipeline of novel treatments and manufacturing innovations to improve patient outcomes.
Sources: Kite Pharma official site
Kite Pharma scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Kite Pharma official site
Kite Pharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Kite Pharma official site
Kite Pharma offers cell therapy treatments for cancer, developed through its research pipeline. The company's offerings are centered on cancer immunotherapy products, including treatments in various stages of research and development within its pipeline, supported by manufacturing innovations.
Sources: Kite Pharma official site
Kite Pharma is owned by or part of Gilead Sciences. Kite Pharma operates in the Healthcare category.
Sources: Wikidata
Kite Pharma's treatments and research are used by cancer patients seeking advanced cell therapy options, healthcare providers who administer or prescribe these treatments, and researchers studying cell therapy and cancer immunotherapy.
Sources: Kite Pharma official site
Kite Pharma is known for its pioneering work in cell therapy as a treatment approach for cancer, and for being a dedicated developer of cancer immunotherapy products within the biomedical engineering field.
Sources: Kite Pharma official site
Kite Pharma scores 53/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Kite Pharma has a limited AI-visibility profile at 53/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a Moz Domain Authority of 51/100. The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Kite Pharma from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Kite Pharma: Kindbody (83/100), Kiierr (83/100), Klinic (83/100), Konica Minolta (83/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.